Atlas Trials

High Risk Neuroblastoma

26 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High Risk Neuroblastoma

RecordFirmDate
Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta As Maintenance Therapy in Chinese Participants With High-Risk Neuroblastoma (NCT05373901)BeiGene2022-06-07
Immunotherapy With Dinutuximab Beta in Combination With Chemotherapy for the Treatment of Patients With Primary Neuroblastoma Refractory to Standard Therapy and With Relapsed or Progressive Disease (NCT05272371)Jagiellonian University2021-12-01
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma (NCT04751383)National Cancer Institute (NCI)2021-08-31
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (NCT04221035)Gustave Roussy, Cancer Campus, Grand Paris2019-11-05
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma (NCT03794349)Children's Oncology Group2019-07-08
Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma (NCT03786783)National Cancer Institute (NCI)2019-03-04
Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma (NCT01041638)National Cancer Institute (NCI)2009-12-21
Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma (NCT03061656)Samsung Medical Center2009-01-01
Naxitamab and GM-CSF in People With Neuroblastoma (NCT04501757)Memorial Sloan Kettering Cancer Center

Track High Risk Neuroblastoma automatically

Every clearance here is in the API, with alerts when new ones post.